financetom
Business
financetom
/
Business
/
Crinetics Pharma's hormonal disorder drug meets main goal in late-stage study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crinetics Pharma's hormonal disorder drug meets main goal in late-stage study
Mar 19, 2024 3:27 AM

March 19 (Reuters) - Crinetics Pharmaceuticals ( CRNX )

said on Tuesday its experimental drug to treat a hormonal

disorder met the main goal in a late-stage study.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CareTrust REIT Closes $500 Million Senior Term Loan
CareTrust REIT Closes $500 Million Senior Term Loan
Jun 2, 2025
11:19 AM EDT, 06/02/2025 (MT Newswires) -- CareTrust REIT ( CTRE ) said Monday it has finalized a new $500 million senior unsecured term loan to support its growth strategy. The loan was arranged through an amendment to its existing credit deal with KeyBank National Association and a group of financial institutions, the company said. This new term loan adds...
Apple challenges 'unreasonable' EU order to open up to rivals
Apple challenges 'unreasonable' EU order to open up to rivals
Jun 2, 2025
(Reuters) - Apple has submitted a legal challenge to an EU order to open up its closed ecosystem to rivals such as Meta and Alphabet's Google, saying the demands are unreasonable and hamper innovation. The European Commission had in March detailed how Apple must comply with the Digital Markets Act, which aims to rein in the power of Big Tech....
Science Applications Misses Quarterly Earnings Views, Expects Business Volatility to Persist
Science Applications Misses Quarterly Earnings Views, Expects Business Volatility to Persist
Jun 2, 2025
11:17 AM EDT, 06/02/2025 (MT Newswires) -- Science Applications International's ( SAIC ) fiscal first-quarter earnings trailed analysts' estimates, while the US government services contractor expects business volatility to continue in the near term amid the Trump administration's focus on gaining efficiency. Adjusted earnings were flat year on year at $1.92 a share for the quarter ended May 2, below...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved